Other
Increase (Decrease) in Prepaid Expense and Other Assets
Vertex Pharmaceuticals Increase (Decrease) in Prepaid Expense and Other Assets decreased by 169.2% to -$173.40M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 717.1%, from $28.10M to -$173.40M. Over 2 years (FY 2022 to FY 2025), Increase (Decrease) in Prepaid Expense and Other Assets shows an upward trend with a 10.1% CAGR.
Analysis
StatementIncome Statement
SectionOther
CategoryLiquidity
SignalContext dependent
VolatilityStable
First reportedQ1 2013
Last reportedQ1 2026May 5, 2026
How to read this metric
Large increases may indicate significant upfront payments for software licenses, insurance, or other long-term service contracts.
Detailed definition
The change in payments made in advance for goods or services to be received in future periods. This represents a use of...
Peer comparison
Standard working capital component found in the cash flow statement of most companies.
Metric ID:
other_increase_decrease_in_prepaid_deferred_expense_and__8bfef6Historical Data
18 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $78.90M | $15.50M | -$67.60M | -$17.70M | $127.20M | $284.50M | $136.43M | $136.43M | $136.43M | $136.43M | -$99.20M | $155.90M | $164.60M | $28.10M | $76.40M | $40.90M | $250.60M | -$173.40M |
| QoQ Change | — | -80.4% | -536.1% | +73.8% | +818.6% | +123.7% | -52.0% | +0.0% | +0.0% | +0.0% | -172.7% | +257.2% | +5.6% | -82.9% | +171.9% | -46.5% | +512.7% | -169.2% |
| YoY Change | — | — | — | -122.4% | +720.6% | — | +301.8% | +870.8% | +7.3% | -52.0% | -172.7% | +14.3% | +20.7% | +128.3% | -51.0% | — | +52.2% | -717.1% |
Range-$173.40M – $284.50M
CAGR+20.4%
Avg YoY Growth+77.0%
Median YoY Growth+14.3%
Increase (Decrease) in Prepaid Expense and Other Assets at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's increase (decrease) in prepaid expense and other assets?
- Vertex Pharmaceuticals (VRTX) reported increase (decrease) in prepaid expense and other assets of -$173.40M in Q1 2026.
- How has Vertex Pharmaceuticals's increase (decrease) in prepaid expense and other assets changed year-over-year?
- Vertex Pharmaceuticals's increase (decrease) in prepaid expense and other assets decreased by 717.1% year-over-year, from $28.10M to -$173.40M.
- What is the long-term trend for Vertex Pharmaceuticals's increase (decrease) in prepaid expense and other assets?
- Over 2 years (2022 to 2025), Vertex Pharmaceuticals's increase (decrease) in prepaid expense and other assets has grown at a 10.1% compound annual growth rate (CAGR), from $326.40M to $396.00M.
- What does increase (decrease) in prepaid expense and other assets mean?
- The change in cash paid upfront for future expenses.